GEODE CAPITAL MANAGEMENT, LLC - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 36 filers reported holding CLEVELAND BIOLABS INC in Q1 2014. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q4 2014$37,000
-38.3%
132,5400.0%0.00%
Q3 2014$60,000
-4.8%
132,5400.0%0.00%
Q2 2014$63,000
-30.0%
132,5400.0%0.00%
Q1 2014$90,000
-41.9%
132,5400.0%0.00%
Q4 2013$155,000
-25.5%
132,540
-0.5%
0.00%
Q3 2013$208,000
-1.0%
133,246
+0.1%
0.00%
Q2 2013$210,000133,1640.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q1 2014
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,826,158$1,244,0000.07%
LADENBURG THALMANN FINANCIAL SERVICES INC. 721,200$507,0000.02%
Winfield Associates, Inc. 15,711$11,0000.01%
Van Cleef Asset Management,Inc 20,000$14,0000.01%
ACG Wealth 25,000$17,0000.01%
TAURUS ASSET MANAGEMENT, LLC 15,000$10,0000.00%
OPPENHEIMER & CO INC 25,500$17,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 500$341,0000.00%
BANK OF AMERICA CORP /DE/ 5,390$4,0000.00%
WELLS FARGO & COMPANY/MN 3,000$2,0000.00%
View complete list of CLEVELAND BIOLABS INC shareholders